Liposomal amphotericin B for transplant patients with fungal infections
Treatments studied
Part of Infections clinical trials.
This study looks at how well liposomal amphotericin B works for treating serious fungal infections in people who have had an organ transplant. It aims to understand the treatment's effectiveness and safety in a real-world setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- You have received a solid organ transplant (such as a kidney, liver, heart, or lung).
- You have a confirmed invasive fungal infection (a serious fungal infection that has spread into your body).
- You are already being treated with liposomal amphotericin B as part of your regular care.
- You do not have a severe allergy to amphotericin B, and you do not have severe liver or kidney problems that would prevent the treatment.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
This study looks at how safe and effective a medicine called liposomal amphotericin B is for treating mold infections in people who have had a liver transplant. It may help doctors understand better ways to fight these serious infections.
This trial looks at how a specific antifungal medicine, called liposomal amphotericin B, given over a longer period, helps prevent serious fungal infections in people undergoing treatment for cancer or receiving a stem cell transplant. It may be an option if you are at high risk for these infections.
This trial tests whether amphotericin B can treat new fungal infections that develop in people with blood cancers even after they have taken preventive antifungal medicine. It may help patients who have a confirmed or suspected fungal infection while on that prevention.
This study looks at how a medicine called L-AmB (a type of amphotericin B, used to treat fungal infections) works in patients who are on ECMO. The goal is to find the right dose for people in your situation.
This study follows children and teens with blood cancers who got a fungal infection while on preventive antifungal medicine. It looks at how well liposomal amphotericin B (AmBisome) works and how safe it is for them.
Hear when a new Solid Organ Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.